AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-006771 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
8,807
Total Value
$8,883.03
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 5, 2026 | Sale | 3,295 | $1.00 | $3,304.88 | 80,875 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 6, 2026 | Sale | 5,512 | $1.01 | $5,578.14 | 75,363 | Direct | โ | View Details |